Literature DB >> 6747662

Comparison between the growth pattern of cell cultures from normal and Duchenne dystrophy muscle.

C Delaporte, M Dehaupas, M Fardeau.   

Abstract

The growth "in vitro" of muscle cells from 12 patients with Duchenne muscular dystrophy (DMD) was compared with that of muscle cells from 20 age-matched controls. In the DMD explants, the lag phase (3 days) was shorter than in controls (6 days). In dissociated cells, plating efficiency (20%) and doubling time (30 h) were identical in DMD and controls. In cultures from three DMD patients, cell clusters were occasionally observed. Myotube morphometry showed significant abnormalities in DMD cultures: the number of myotubes per field was 8.2 +/- 0.8 and 26.7 +/- 0.6 in controls, P less than 0.001; myotube length (151 +/- 20 micron) and diameter (8.2 +/- 0.9 micron) in DMD cultures were half the control values (312 +/- 46 micron and 15.6 +/- 1.2 micron, respectively, P less than 0.001). The number of nuclei per myotube in DMD was one-quarter of that in control muscle (4.0 +/- 0.2 vs 15.8 +/- 2.2, P less than 0.001). It is concluded that DMD cultures show cellular heterogeneity with the presence of fibroblasts and non-fusing myoblasts; furthermore they show delayed myoblast fusion and poor myotube differentiation.

Entities:  

Mesh:

Year:  1984        PMID: 6747662     DOI: 10.1016/0022-510x(84)90033-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  28 in total

Review 1.  Are human and mouse satellite cells really the same?

Authors:  Luisa Boldrin; Francesco Muntoni; Jennifer E Morgan
Journal:  J Histochem Cytochem       Date:  2010-07-19       Impact factor: 2.479

2.  Hexose transport in human myoblasts.

Authors:  O T Mesmer; T C Lo
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

3.  Increased acetylcholine sensitivity in Duchenne muscular dystrophy myotubes.

Authors:  G Meola; E Mancinelli; L Geremia; G Scarlato
Journal:  Ital J Neurol Sci       Date:  1991-04

4.  In vitro myotrophic effect of serum kappa chain immunoglobulins from a patient with kappa light chain myeloma and muscular hypertrophy.

Authors:  C Delaporte; B Varet; M Fardeau; D Nochy; A Ract
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

5.  Expression of oxidative phosphorylation genes in muscle cell cultures from patients with mitochondrial myopathies.

Authors:  J M Collombet; H Faure-Vigny; G Mandon; R Dumoulin; S Boissier; A Bernard; B Mousson; G Stepien
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

6.  Voltage-dependent channels of human muscle cultures.

Authors:  A Trautmann; C Delaporte; A Marty
Journal:  Pflugers Arch       Date:  1986-02       Impact factor: 3.657

Review 7.  Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery.

Authors:  Alec S T Smith; Jennifer Davis; Gabsang Lee; David L Mack; Deok-Ho Kim
Journal:  Drug Discov Today       Date:  2016-04-22       Impact factor: 7.851

8.  Duchenne muscular dystrophy hiPSC-derived myoblast drug screen identifies compounds that ameliorate disease in mdx mice.

Authors:  Congshan Sun; In Young Choi; Yazmin I Rovira Gonzalez; Peter Andersen; C Conover Talbot; Shama R Iyer; Richard M Lovering; Kathryn R Wagner; Gabsang Lee
Journal:  JCI Insight       Date:  2020-06-04

9.  Exon 45 skipping through U1-snRNA antisense molecules recovers the Dys-nNOS pathway and muscle differentiation in human DMD myoblasts.

Authors:  Valentina Cazzella; Julie Martone; Chiara Pinnarò; Tiziana Santini; Shyam Sundar Twayana; Olga Sthandier; Adele D'Amico; Valeria Ricotti; Enrico Bertini; Francesco Muntoni; Irene Bozzoni
Journal:  Mol Ther       Date:  2012-09-11       Impact factor: 11.454

10.  Sodium and potassium currents in freshly isolated and in proliferating human muscle satellite cells.

Authors:  M Hamann; H Widmer; A Baroffio; J P Aubry; R M Krause; A Kaelin; C R Bader
Journal:  J Physiol       Date:  1994-03-01       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.